Diagnostic biomarker of asbestos-related mesothelioma: Example of translational research

May 31, 2007 | Comments Off on Diagnostic biomarker of asbestos-related mesothelioma: Example of translational research

Cancer Science. 2007 Aug;98(8):1147-51. Epub 2007 May 25. [Link] Okio H, Kazu S, Masahiro M. Department of Pathology and Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Tokyo, Japan. ohino@med.juntendo.ac.jp…

Registration of selected cases of occupational cancer (1994-2002) with the Danish National Board of Industrial Injuries

May 31, 2007 | Comments Off on Registration of selected cases of occupational cancer (1994-2002) with the Danish National Board of Industrial Injuries

Ugeskr for Laeger. 2007 Apr 30;169(18):1674-8. [Link] Hansen J, Rasmussen TR, Omland Ø, Olsen JH; Danish National Board of Industrial Injuries. Kraeftens Bekaempelse, Institut for Epidemiologisk Kraeftforskning. Abstract Introduction: Persons…

The risk of mesothelioma from exposure to chrysotile asbestos

May 31, 2007 | Comments Off on The risk of mesothelioma from exposure to chrysotile asbestos

Current Opinion in Pulmonary Medicine. 13(4):334-338, July 2007. [Link] Yarborough, Charles M Pulmonary and Thoracic Oncology Department, Hopital Calmette, Lille, France. Abstract Purpose of review: This review assesses the risk…

Biomarkers for mesothelioma

May 31, 2007 | Comments Off on Biomarkers for mesothelioma

Current Opinion in Pulmonary Medicine. 13(4):339-343, July 2007. [Link] Scherpereel A, Lee YC. Pulmonary and Thoracic Oncology Department, Hopital Calmette, Lille, France. Abstract Purpose of review: Mesothelioma is an incurable…

Malignant pleural mesothelioma: current concepts in treatment

May 31, 2007 | Comments Off on Malignant pleural mesothelioma: current concepts in treatment

Nature Clinical Practice Oncology. (2007) 4, 344-352 [Link] Athanasios Tsiouris* and Robin K Walesby Correspondence *Basement flat 2, 359 Camden Road, London N7 0SH, UK Email athtsiouris@hotmail.com Abstract Malignant pleural…

The Rochdale asbestos cancer studies and the politics of epidemiology: what you see depends on where you sit

May 26, 2007 | Comments Off on The Rochdale asbestos cancer studies and the politics of epidemiology: what you see depends on where you sit

International Journal of Occupational and Environmental Health. 2007 Jan-Mar;13(1):70-9. [Link] Tweedale G. Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. marchevsky@cshs.org Abstract The history…

Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma

May 25, 2007 | Comments Off on Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma

Applied Immunohistochemistry & Molecular Morphology. 5(2):140-144, June 2007. [Link] Marchevsky AM, Wick MR. Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. marchevsky@cshs.org Abstract There…

Management options for malignant pleural mesothelioma: clinical and cost considerations

May 25, 2007 | Comments Off on Management options for malignant pleural mesothelioma: clinical and cost considerations

Drugs. 2007;67(8):1149-65. [Link] Goudar RK. Department of Medicine, Duke University Medical Center, Durham, North Carolina 27701, USA. gouda001@mc.duke.edu Abstract Malignant pleural mesothelioma (MPM) is a resistant form of lung cancer…

Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma

May 25, 2007 | Comments Off on Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma

Cancer Chemotherapy and Pharmacology. 2007 May 24; [Epub ahead of print] [Link] Gordon GJ, Mani M, Maulik G, Mukhopadhyay L, Yeap BY, Kindler HL, Salgia R, Sugarbaker DJ, Bueno R.…

Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer

May 24, 2007 | Comments Off on Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer

Revue des Maladies Respiratoires. 2007 May;24(5):635-8. [Link] C. Tummino[1], F. Barlesi[1], C. Tchouhadjian[1], A.M. Tasei[2], C. Gaudy-Marqueste[3], M.A. Richard[3], P. Astoul[1] [1] Faculté de Médecine, Université de la Méditerranée-Assistance Publique…

Categories